METTL1 and neoplasm: After DEN/sorafenib treatment for 18 weeks (Fig. 7a), massive tumor burden was developed in esophagus of the Mettl1 cKI mice, while only few and small lesions occurred in the esophagus of control mice (Fig. 7b, c).